Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease

J Neural Transm (Vienna). 1996;103(10):1205-10. doi: 10.1007/BF01271205.

Abstract

alpha 1-Antichymotrypsin (ACT), a component of the senile plaque of the Alzheimer's disease (AD) brain, has a possible role as a molecular chaperone in developing AD pathology. This study was a search for the possible association of the two structural polymorphisms of ACT, Ala15-->Thr and Met389-->Val in the Japanese population. In 101 AD patients, genotype and allele frequencies of the two polymorphisms did not differ from those of 104 age-matched healthy controls. However, in those subjects in which the apolipoprotein epsilon 4 allele was absent, the frequency of the Ala15 homozygote was significantly higher in the AD patients than in controls. This suggests that the Ala15 homozygote state may be a susceptibility marker for AD, interacting with apolipoprotein E genotype.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / ethnology
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Asian People / genetics
  • Disease Susceptibility
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Point Mutation*
  • Polymorphism, Genetic*
  • Risk Factors
  • alpha 1-Antichymotrypsin / genetics*

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • alpha 1-Antichymotrypsin